Expected earnings - Lucid Diagnostics Inc.
Source: US Earnings Reports
Lucid Diagnostics Inc. (LUCD) is expected to report $-0.1 for Q2 2025
Lucid Diagnostics Inc.
NASDAQ: LUCD
LUCD Trading
-6.3% G/L:
$1.265 Last:
612,403 Volume:
$1.31 Open:
LUCD Latest News
March 12, 2026 09:01:00 am
Lucid Diagnostics to Hold Fourth Quarter and Full Year 2025 Business Update Conference Call and Webcast on March 26, 2026
February 04, 2026 08:01:00 am
PAVmed Closes Preferred Stock and Senior Secured Note Financings, Eliminating All Previously Outstanding Convertible Securities
January 21, 2026 08:00:00 am
Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard®
LUCD Stock Data
$166,596,432
87,428,706
0.61%
29
N/A
Medical Equipment & Supplies
Healthcare
US
New York
